Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis

Autoimmunity Reviews

Volumn 12, Issue 2, 2012, Pages 137-143

  Op De Beéck, Katrijn ^a   Vermeersch, Pieter ^b   Verschueren, Patrick ^b   Westhovens, René ^b   Mariën, Godelieve ^b   Blockmans, Daniel ^b   Bossuyt, Xavier ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; CARBENOXOLONE; DOUBLE STRANDED DNA; JO 1 ANTIBODY; LA ANTIBODY; RIBONUCLEOPROTEIN; RIBOSOME PROTEIN; RO ANTIBODY; SCL 70 ANTIBODY; SM ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; AUTOMATED MULTIPLEX IMMUNOASSAY; BLOOD DONOR; CENTROMERE; CHROMATIN; CHRONIC FATIGUE SYNDROME; DERMATOMYOSITIS; DILUTION; HUMAN; IMMUNOASSAY; IMMUNOFLUORESCENCE; MIXED CONNECTIVE TISSUE DISEASE; MYOSITIS; POLYMYOSITIS; REVIEW; RHEUMATIC DISEASE; SJOEGREN SYNDROME; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

ANTIBODIES, ANTINUCLEAR; CONNECTIVE TISSUE DISEASES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; SENSITIVITY AND SPECIFICITY;

EID: 84870236080     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2012.02.013     Document Type: Review

References (23)

1. Solomon D.H., Kavanaugh A.J., Schur P.H. American College of Rheumatology Ad Hoc Committee on Immunologic Testing Guidelines. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum 2002, 47:434-444.
2. Bizzaro N., Wiik A. Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. Clin Exp Rheumatol 2004, 22:349-355.
3. Damoiseaux J.G., Tervaert J.W. From ANA to ENA: how to proceed?. Autoimmun Rev 2006, 5:10-17.
4. Binder S.R., Genovese M.C., Merrill J.T., Morris R.I., Metzger A.L. Computer-assisted pattern recognition of autoantibody results. Clin Diagn Lab Immunol 2005, 12:1353-1357.
5. Shovman O., Barzilai O., Shinar E., Larida B., Zandman-Goddard G., Binder S.R., et al. Evaluation of the BioPlex 2200 ANA screen: analysis of 510 healthy subjects: incidence of natural/predictive autoantibodies. Ann N Y Acad Sci 2005, 1050:380-388.
6. Desplat-Jego S., Bardin N., Larida B., Sanmarco M. Evaluation of the BioPlex 2200 ANA. Screen for the Detection of Antinuclear Antibodies and Comparison with Conventional Methods. Ann N Y Acad Sci 2007, 1109:245-255.
7. Hanly J.G., Su L., Farewell V., Fritzler M.J. Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus. J Immunol Methods 2010, 358:75-80.
8. Moder K.G., Wener M.H., Weisman M.H., Ishimori M.L., Wallace D.J., Buckeridge D.L., et al. Measurement of antinuclear antibodies by multiplex immunoassay: a prospective, multicenter clinical evaluation. J Rheumatol 2007, 34:978-986.
9. Bardin N., Desplat-Jego S., Daniel L., Jourde Chiche N., Sanmarco M. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus. Autoimmunity 2009, 42:63-68.
10. Hanly J.G., Thompson K., McCurdy G., Fougere L., Theriault C., Wilton K. Measurement of autoantibodies using multiplex methodology in patients with systemic lupus erythematosus. J Immunol Methods 2010, 352:147-152.
11. Op De Beéck K., Vermeersch P., Verschueren P., Westhovens R., Mariën G., Blockmans D., et al. Detection of antinuclear antibodies by indirect immunofluorescence and by solid phase assay. Autoimmun Rev 2011, 10:801-808.
12. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E. European Study Group on Classification Criteria for Sjogren's Syndrom. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002, 61:554-558.
13. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997, 40:1725.
14. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980, 23:581-590.
15. Bohan A., Peter J.B., Bowman R.L., Pearson C.M. Computer-assisted analysis of 153 patients with polymyositis and dermatomyositis. Medicine (Baltimore) 1977, 56:255-286.
16. Alarcón-Segovia D., Cardiel M.H. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 1989, 16:328-334.
17. Bossuyt X., Frans J., Hendrickx A., Godefridis G., Westhovens R., Mariën G. Detection of anti-SSA antibodies by indirect immunofluorescence. Clin Chem 2004, 50:2361-2369.
18. Brouwer R., Hengstman G.J., Vree Egberts W., Ehrfeld H., Bozic B., Ghirardello A., et al. Autoantibody profiles in the sera of European patients with myositis. Ann Rheum Dis 2001, 60:116-123.
19. Bossuyt X. Clinical performance characteristics of a laboratory test. A practical approach in the autoimmune laboratory. Autoimmun Rev 2009, 8:543-548.
20. American college of rheumatology ad hoc committee on immunologic testing guidelines. Guidelines for immunologic laboratory testing in the rheumatic diseases: an introduction. Arthritis Rheum (Arthritis Care Res) 2002, 27:429-433.
21. Vermeersch P., Bossuyt X. Comparative analysis of different approaches to report diagnostic accuracy. Arch Intern Med 2010, 170:734-735.
22. Bossuyt X., Coenen D., Fieuws S., Verschueren P., Westhovens R., Blanckaert N. Likelihood ratios as a function of antibody concentration for anti-cyclic citrullinated peptide antibodies and rheumatoid factor. Ann Rheum Dis 2009, 68:287-289.
23. Vermeersch P., Blockmans D., Bossuyt X. Use of likelihood ratios can improve the clinical usefulness of enzyme immunoassays for the diagnosis of small-vessel vasculitis. Clin Chem 2009, 55:1886-1888.